Circulating tumor (ct) DNA analysis to monitor response and resistance to ensartinib in patients (pts) with ALK+ non-small cell lung cancer (NSCLC). Annals of oncology : official journal of the European Society for Medical Oncology Horn, L., Whisenant, J. G., Wakelee, H., Reckamp, K. L., Qiao, H., Du, L., Hernandez, J., Huang, V., Waqar, S. N., Patel, S., Sanborn, R. E., Shaffer, T., Garg, K., Holzhausen, A., Harrow, K., Liang, C., Lim, L. P., Li, M., Lovly, C. M. 2019; 30 Suppl 2: ii48

View details for DOI 10.1093/annonc/mdz063.010

View details for PubMedID 32131242